https://www.selleckchem.com/pr....oducts/monocrotaline
Further prognostic improvements are expected through the selection of teams particularly experienced in the management of individuals with PWS and the discovery of new drugs. To define an optimal cutoff time to distinguish early and late recurrence in hepatocellular carcinoma (HCC) patients after radiofrequency ablation (RFA), and to determine the risk factors and patterns of early recurrence. This retrospective study included HCC patients who developed recurrence after RFA as the primary therapy at three Chinese hospitals from Ja
Like
Comment
Share
